Trial Profile
A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AstroStem, Autologous Adipose Tissue Derived Mesenchymal Stem Cells, in Patients With Alzheimer's Disease
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Adipose stem cell therapy Anterogen (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Nature cell
- 30 Dec 2019 Status changed from active, no longer recruiting to completed.
- 08 May 2019 Planned End Date changed from 1 Jun 2019 to 1 Sep 2019.
- 08 May 2019 Planned primary completion date changed from 1 Jun 2019 to 1 Aug 2019.